Regulatory authorities in the European Union (EU), the United States (U.S.), and Canada have approved a new state-of-the-art Restylane® syringe for use with a range of Restylane NASHA® lidocaine pro...
Excellent momentum and record operating profit
Total business volume rises 8.11 percent and reaches 186.9 billion euros with contributions from all segments
...
Results from an interim analysis of the OLYMPIA long-term extension (LTE) study show that Nemluvio maintained long-term disease control up to three years, with clinically meaningful improvements in it...
Private 5G delivered as a fully managed global service with consistent security and operations worldwide
Edge AI and physical AI embedded directly into enterprise connectivity for real-time, autonomou...
